The $1.2 billion Dermavant acquisition appears strategically acceptable but carries significant risks due to market ...

CWA Asset Management Group LLC acquired a new position in Organon & Co. (NYSE:OGN – Free Report) in the third quarter, ...

Despite announcing strong earnings, Organon & Co.'s ( NYSE:OGN ) stock was sluggish. We did some digging and found ...

On Tuesday, Organon & Co (OGN) stock saw a decline, ending the day at $16.46 which represents a decrease of $-0.46 or -2.72% from the prior close of $16.92. The stock opened at $16.74 and touched a ...

Looking at the universe of stocks we cover at Dividend Channel, in trading on Friday, shares of Organon & Co (Symbol: OGN) were yielding above the 6% mark based on its quarterly dividend ...

Organon & Co. ( NYSE:OGN ) shareholders are probably feeling a little disappointed, since its shares fell 3.1% ...

Organon (OGN) stock on watch as FDA delays a potential label expansion for its VTAMA cream, impacting 2025 EBITDA margin and ...

International Assets Investment Management LLC increased its holdings in Organon & Co. (NYSE:OGN – Free Report) by 1,851.8% in the third quarter, HoldingsChannel.com reports. The institutional ...

Evercore ISI analyst Umer Raffat maintained a Buy rating on Organon (OGN – Research Report) today. The company’s shares closed ...

On Monday, Organon & Co (OGN) stock saw a modest uptick, ending the day at $17.46 which represents a slight increase of $0.30 or 1.75% from the prior close of $17.16. The stock opened at $17.36 and ...